Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients.

Harrington R, Kindermann SL, Hou Q, Taylor RJ, Azie N, Horn DL.

Curr Med Res Opin. 2017 Oct;33(10):1803-1812. doi: 10.1080/03007995.2017.1354824. Epub 2017 Aug 22.

PMID:
28699797
2.

Erratum: Effects of age and hearing mechanism on spectral resolution in normal hearing and cochlear-implanted listeners [J. Acoust. Soc. Am. 141(1), 613-623 (2017)].

Horn DL, Dudley DJ, Dedhia K, Nie K, Drennan WR, Won JH, Rubinstein JT, Werner LA.

J Acoust Soc Am. 2017 May;141(5):2977. doi: 10.1121/1.4979463. No abstract available.

PMID:
28599570
3.

Progression of Unilateral Hearing Loss in Children With and Without Ipsilateral Cochlear Nerve Canal Stenosis: A Hazard Analysis.

Purcell PL, Shinn JR, Coggeshall SS, Phillips G, Paladin A, Sie KCY, Horn DL.

Otol Neurotol. 2017 Jul;38(6):e138-e144. doi: 10.1097/MAO.0000000000001452.

4.

Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy.

Zorzopulos J, Opal SM, Hernando-Insúa A, Rodriguez JM, Elías F, Fló J, López RA, Chasseing NA, Lux-Lantos VA, Coronel MF, Franco R, Montaner AD, Horn DL.

World J Stem Cells. 2017 Mar 26;9(3):45-67. doi: 10.4252/wjsc.v9.i3.45. Review.

5.

Effects of age and hearing mechanism on spectral resolution in normal hearing and cochlear-implanted listeners.

Horn DL, Dudley DJ, Dedhia K, Nie K, Drennan WR, Won JH, Rubinstein JT, Werner LA.

J Acoust Soc Am. 2017 Jan;141(1):613. doi: 10.1121/1.4974203.

6.

Clinically small tonsils are typically not obstructive in children during drug-induced sleep endoscopy.

Miller C, Purcell PL, Dahl JP, Johnson K, Horn DL, Chen ML, Chan DK, Parikh SR.

Laryngoscope. 2017 Aug;127(8):1943-1949. doi: 10.1002/lary.26447. Epub 2016 Dec 23.

7.

Spectral Ripple Discrimination in Normal-Hearing Infants.

Horn DL, Won JH, Rubinstein JT, Werner LA.

Ear Hear. 2017 Mar/Apr;38(2):212-222. doi: 10.1097/AUD.0000000000000373.

8.

Airway Obstruction during Drug-Induced Sleep Endoscopy Correlates with Apnea-Hypopnea Index and Oxygen Nadir in Children.

Dahl JP, Miller C, Purcell PL, Zopf DA, Johnson K, Horn DL, Chen ML, Chan DK, Parikh SR.

Otolaryngol Head Neck Surg. 2016 Oct;155(4):676-80. doi: 10.1177/0194599816653113. Epub 2016 Jun 14.

PMID:
27301902
9.

A Skin-Sparing Approach to the Treatment of Necrotizing Soft-Tissue Infections: Thinking Reconstruction at Initial Debridement.

Tom LK, Wright TJ, Horn DL, Bulger EM, Pham TN, Keys KA.

J Am Coll Surg. 2016 May;222(5):e47-60. doi: 10.1016/j.jamcollsurg.2016.01.008. Epub 2016 Jan 23. No abstract available.

PMID:
26968320
10.

Bony cochlear nerve canal stenosis and speech discrimination in pediatric unilateral hearing loss.

Purcell PL, Iwata AJ, Phillips GS, Paladin AM, Sie KC, Horn DL.

Laryngoscope. 2015 Jul;125(7):1691-6. doi: 10.1002/lary.25087. Epub 2015 Apr 15.

PMID:
25878020
11.

Acoustic temporal modulation detection in normal-hearing and cochlear implanted listeners: effects of hearing mechanism and development.

Park MH, Won JH, Horn DL, Rubinstein JT.

J Assoc Res Otolaryngol. 2015 Jun;16(3):389-99. doi: 10.1007/s10162-014-0499-z. Epub 2015 Mar 20.

12.

Supraglottoplasty for sleep endoscopy diagnosed sleep dependent laryngomalacia.

Mase CA, Chen ML, Horn DL, Parikh SR.

Int J Pediatr Otorhinolaryngol. 2015 Apr;79(4):511-5. doi: 10.1016/j.ijporl.2015.01.018. Epub 2015 Jan 23.

PMID:
25698459
13.

Migration of a cochlear implant ground electrode through the calvarium of a pediatric patient.

Mitchell RM, Horn DL.

Int J Pediatr Otorhinolaryngol. 2015 Feb;79(2):278-80. doi: 10.1016/j.ijporl.2014.11.031. Epub 2014 Dec 3.

PMID:
25547958
14.

First branchial cleft anomalies: otologic manifestations and treatment outcomes.

Shinn JR, Purcell PL, Horn DL, Sie KC, Manning SC.

Otolaryngol Head Neck Surg. 2015 Mar;152(3):506-12. doi: 10.1177/0194599814562773. Epub 2014 Dec 18.

PMID:
25524898
15.

The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis.

Chahin A, Opal SM, Zorzopulos J, Jobes DV, Migdady Y, Yamamoto M, Parejo N, Palardy JE, Horn DL.

Antimicrob Agents Chemother. 2015 Feb;59(2):1225-9. doi: 10.1128/AAC.03923-14. Epub 2014 Dec 15.

16.

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE.

PLoS One. 2014 Jul 3;9(7):e101510. doi: 10.1371/journal.pone.0101510. eCollection 2014.

17.

Interarytenoid sodium carboxymethylcellulose gel injection for management of pediatric aspiration.

Horn DL, DeMarre K, Parikh SR.

Ann Otol Rhinol Laryngol. 2014 Dec;123(12):852-8. doi: 10.1177/0003489414539129. Epub 2014 Jun 24.

PMID:
24963090
18.

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.

Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, Kauffman CA.

Mycoses. 2014 Nov;57(11):652-8. doi: 10.1111/myc.12212. Epub 2014 Jun 18.

19.

A new scoring system for upper airway pediatric sleep endoscopy.

Chan DK, Liming BJ, Horn DL, Parikh SR.

JAMA Otolaryngol Head Neck Surg. 2014 Jul;140(7):595-602. doi: 10.1001/jamaoto.2014.612.

PMID:
24810174
20.

Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.

Franco R, Rodriguez JM, Elías F, Hernando-Insúa A, Fló J, López R, Nagle C, Lago N, Zorzopulos J, Horn DL, Montaner AD.

Nucleic Acid Ther. 2014 Aug;24(4):267-82. doi: 10.1089/nat.2013.0479. Epub 2014 Apr 10.

21.

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study.

Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL.

HIV AIDS (Auckl). 2014 Mar 13;6:39-47. doi: 10.2147/HIV.S53910. eCollection 2014.

22.

Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.

Yang H, Chaudhari P, Zhou ZY, Wu EQ, Patel C, Horn DL.

Appl Health Econ Health Policy. 2014 Feb;12(1):85-93. doi: 10.1007/s40258-013-0072-7.

PMID:
24385260
23.

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups.

Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL.

Clinicoecon Outcomes Res. 2013 Oct 24;5:507-17. doi: 10.2147/CEOR.S46834. eCollection 2013.

24.

Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.

Kontoyiannis DP, Azie N, Franks B, Horn DL.

Mycoses. 2014 Apr;57(4):240-6. doi: 10.1111/myc.12149. Epub 2013 Oct 22.

PMID:
24147728
25.

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.

Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):361-7. doi: 10.1016/j.diagmicrobio.2013.04.001.

PMID:
23774005
26.

Imaging of pediatric floor of mouth lesions.

Edwards RM, Chapman T, Horn DL, Paladin AM, Iyer RS.

Pediatr Radiol. 2013 Mar;43(5):523-35. doi: 10.1007/s00247-013-2620-6. Epub 2013 Feb 22. Review.

PMID:
23429804
27.

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL.

J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13.

PMID:
22898389
28.

Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature.

Slenker AK, Keith SW, Horn DL.

Diagn Microbiol Infect Dis. 2012 May;73(1):89-93. doi: 10.1016/j.diagmicrobio.2012.02.004. Review.

PMID:
22578942
29.

Endoscopic anterior cricoid split with balloon dilation in infants with failed extubation.

Horn DL, Maguire RC, Simons JP, Mehta DK.

Laryngoscope. 2012 Jan;122(1):216-9. doi: 10.1002/lary.22155. Epub 2011 Nov 17.

PMID:
22095839
30.

Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials.

Horn DL, Ostrosky-Zeichner L, Morris MI, Ullmann AJ, Wu C, Buell DN, Kovanda LL, Cornely OA.

Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):223-9. doi: 10.1007/s10096-009-0843-0. Epub 2009 Dec 15.

PMID:
20013016
31.

Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.

Davis JA, Horn DL, Marr KA, Fishman JA.

Transpl Infect Dis. 2009 Oct;11(5):432-7. doi: 10.1111/j.1399-3062.2009.00424.x. Epub 2009 Jul 22.

PMID:
19638005
32.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.

Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.

PMID:
19441981
33.

Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.

Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ; PATH Alliance.

Diagn Microbiol Infect Dis. 2009 Jun;64(2):152-7. doi: 10.1016/j.diagmicrobio.2009.03.007. Epub 2009 Apr 18.

PMID:
19376667
34.

Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):407-14. Epub 2007 Sep 20.

PMID:
17888614
35.

Visual-motor integration skills of prelingually deaf children: implications for pediatric cochlear implantation.

Horn DL, Fagan MK, Dillon CM, Pisoni DB, Miyamoto RT.

Laryngoscope. 2007 Nov;117(11):2017-25.

36.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN.

Clin Infect Dis. 2007 Oct 1;45(7):883-93. Epub 2007 Aug 29. Erratum in: Clin Infect Dis. 2008 Jul 15;47(2):302.

PMID:
17806055
37.

Neuropsychological correlates of vocabulary, reading, and working memory in deaf children with cochlear implants.

Fagan MK, Pisoni DB, Horn DL, Dillon CM.

J Deaf Stud Deaf Educ. 2007 Fall;12(4):461-71. Epub 2007 Jun 7.

38.
39.

Behavioral assessment of prelingually deaf children before cochlear implantation.

Horn DL, Pisoni DB, Sanders M, Miyamoto RT.

Laryngoscope. 2005 Sep;115(9):1603-11.

40.

Development of visual attention skills in prelingually deaf children who use cochlear implants.

Horn DL, Davis RA, Pisoni DB, Miyamoto RT.

Ear Hear. 2005 Aug;26(4):389-408.

41.

Behavioral inhibition and clinical outcomes in children with cochlear implants.

Horn DL, Davis RA, Pisoni DB, Miyamoto RT.

Laryngoscope. 2005 Apr;115(4):595-600.

42.

Visual attention, behavioral inhibition and speech/language outcomes in deaf children with cochlear implants.

Horn DL, Davisa RA, Pisoni DB, Miyamoto RT.

Int Congr Ser. 2004 Nov;1273:332-335.

43.
44.

Twenty years of therapy for HIV-1 infection.

Pomerantz RJ, Horn DL.

Nat Med. 2003 Jul;9(7):867-73.

PMID:
12835707
45.

Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis.

Olszyna DP, Opal SM, Prins JM, Horn DL, Speelman P, van Deventer SJ, van der Poll T.

J Infect Dis. 2000 Dec;182(6):1731-7. Epub 2000 Oct 23.

PMID:
11069246
46.

What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.

Horn DL, Morrison DC, Opal SM, Silverstein R, Visvanathan K, Zabriskie JB.

Clin Infect Dis. 2000 Oct;31(4):851-8. Epub 2000 Oct 11. Review.

PMID:
11049761
47.

Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Silverstein R, Wood JG, Xue Q, Norimatsu M, Horn DL, Morrison DC.

Infect Immun. 2000 Apr;68(4):2301-8.

48.
49.

Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages.

Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC.

J Immunol. 1999 Oct 15;163(8):4095-9.

50.

Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain.

Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F, Saido TC, Cole GM.

J Neurosci. 1998 Oct 15;18(20):8311-21.

Supplemental Content

Support Center